The classical-baseline gate
No advantage claim raises a verdict without a named benchmark, a problem size and a classical comparator. Missing any → it is flagged needs-baseline and cannot reach Proceed. The software enforces it.
Home / Solutions
Every Veriqa engagement runs the same discipline — claims graded against a classical baseline, every line sourced, nothing reaching a Proceed verdict without a comparator. What changes is the decision in front of you. Pick the one you own.
Each solution is a first-class engagement with its own inputs, outputs and buyer — built on the same neutral evidence layer.
Diligence quantum startups, public-company narratives and M&A targets on the evidence — hype-risk scored, baselines demanded, a Proceed / Monitor / Require-further-diligence memo you can put in front of an IC.
Explore investor diligence →Turn a cryptographic inventory into a phased post-quantum migration plan mapped to NIST FIPS 203/204/205, prioritised by harvest-now-decrypt-later exposure and data shelf-life.
Explore PQC migration →Separate AI-assisted design, classical simulation and selective quantum refinement into a conservative, patent-ready evidence package — wet-lab gaps flagged, no overclaiming.
Explore molecular-design evidence →Map quantum sensing, navigation (PNT), secure comms and dual-use programs to evidence-graded readiness and realistic procurement paths — TRL-honest, hype-free.
Explore defense diligence →Deciding whether to back, buy or partner with a quantum company? That is investor & corp-dev diligence — start there.
On the hook for cryptographic risk and a migration clock? That is the PQC / security track.
Evaluating a molecular-design or simulation claim? Pharma & R&D evidence packaging.
Assessing a sensing, PNT, comms or dual-use program? Defense & dual-use readiness.
Still unsure? Send us the company, claim, paper or program and we will tell you which engagement fits — and scope it.
Tell us the company, claim, paper or program. We respond with scope and a fixed price within two business days.